• Oricef
  • Oricef
  • Oricef
  • Oricef
  • Oricef
  • Oricef
  • Oricef

Oricef

Ceftriaxone

Description
The bactericidal activity of ceftriaxone results from inhibition of bacterial cell wall synthesis. Ceftriaxone exerts in-vitro activity against a wide range of gram-negative and gram-positive microorganisms. Ceftriaxone is highly stable to most b-lactamases, both penicillinases and cephalosporinases, of gram-positive and gram-negative bacteria.

Indications
Sepsis; meningitis; abdominal infections; infections of the bones, joints, soft tissue skin and of wounds; infections in patients with impaired defense mechanisms; renal and urinary tract infections; respiratory tract infections, particularly pneumonia and ear nose and throat infections; genital infections, Perioperative prophylaxis of infections.

Supply
Packs for i.m. injection (containing 1 vial with dry substance equivalent to 0.25 g, 0.5 g or 1 g ceftriaxone and 1 ampoule containing 2 ml or 3.5 ml of 1% lidocaine solution, disposable syringe and a alcoholic prep pad)
Packs for i.v. injection (containing 1 vial with dry substance equivalent to 0.25 g, 0.5 g or 1 g ceftriaxone and 1 ampoule containing 5 ml or 10 ml of water for injections, disposable syringe and a alcoholic prep pad.
Packs for i.v. infusion (containing 1 vial with dry substance equivalent to 2 g ceftriaxone with 20 ml of WFI, disposable syringe, alcoholic prep pad and a butterfly needle).

 

Related Products